Pralsetinib: a promising new drug in the treatment of cancerWith an ongoing phase 3 study, pralsetinib seems to be a promising candidate for the treatment of different types of cancer because of the presence of oncogenic rearranged during transfection) fusions. Inside the decision to extend FP trainingMany family doctors remain concerned about the CFPC’s decision to extend family medicine training from two years to three. Health Canada approves Pfizer COVID-19 vaccine for kids six months to four years old It's the second vaccine to be approved for that age group, after Health Canada approved Moderna's Spikevax shot in July. Licensed in as little as six months: new shorter supervision period and faster licensing decisions for IMGs in Nova Scotia New licensing pathway includes an orientation program for IMGs new to practicing in the province. The (pharmacy) funny pages: Stop by the lab! Your weekly dose of giggles! Rare victory: How a retiring rural doctor found his own replacement 'It was an easy fix,' said Dr. Marcel Aucoin, who retired in August after 26 years of family medicine in the Nova Scotia community of Chetticamp. Staffing shortages, more complex disease pushing up surgery wait times in Nova Scotia Operating rooms are working at full speed to get through a backlog of surgeries from the last two COVID-19 waves, Dr. Gail Darling, head of surgery for Nova Scotia Health's central zone, said in a recent interview. How can Canada bolster its pharmaceutical security? And what are other countries doing to shore up their own supplies? Seven months in and Alberta's RESIDE program has only attracted one doctor to the province Announced in February, only 18 applications have come through, and only one doc has a set start-date for a much-needed rural residency. The focused FP Why are many FPs eschewing comprehensive, cradle-to-grave practices, and what does it mean for longitudinal care? First Previous 317 318 319 320 321 Next Last